Valuation (48%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -52.12 | 7.74 |
| PEG Ratio (TTM) | 0.37 | 0.28 |
| P/S Ratio (TTM) | 1.35 | 2.85 |
| P/B Ratio (TTM) | 4.69 | 1.61 |
| P/FCF Ratio (TTM) | 20.73 | 39.72 |
| Price to 5YR AVG Earnings Ratio | 15.38 | 16.14 |
| Price to 5YR AVG FCF Ratio | -10.15 | 33.17 |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -0.10% | 8.18% |
| ROE (TTM) | -12.15% | 17.38% |
| Net Profit Margin (TTM) | -2.64% | 30.70% |
| ROIC 5YR AVG | -9.46% | 6.65% |
Growth (43%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 30.40% | -7.64% | 1,917.70% |
| Revenue | 1.70% | -0.75% | -0.88% |
| Net Income | 23.72% | -3.36% | 1,804.25% |
| Cash Flow | 448.35% | -507.23% | -291.74% |
Health (46%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 3.42 | 24.41 |
| Quick Ratio (TTM) | 3.42 | 23.19 |
| D/E Ratio (TTM) | 1.19 | 0.22 |
| Interest Coverage (TTM) | 2.50 | 10.66 |
| Piotroski F-Score | 4 | 6 |
| Altman Z-Score | 0.12 | 2.66 |
| LTL to 5YR AVG FCF | -8.16 | 4.46 |
| Shares Outstanding Growth 5YR AVG | -8.84% | -2.54% |